Cushing鈥檚 disease: A single centre鈥檚 experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy

详细信息    查看全文

• 作者：P.J. Wilson ; J.R. Williams ; R.I. Smee
• 关键词：Cushing&rsquo ; s disease ; Endocrine therapy ; Fractionated radiotherapy ; Linear accelerator ; Post treatment complications ; Stereotactic radiosurgery ; Tumour control
• 刊名：Journal of Clinical Neuroscience
• 出版年：January, 2014
• 年：2014
• 卷：21
• 期：1
• 页码：100-106
• 全文大小：638 K

文摘

Cushing鈥檚 disease is hypercortisolaemia secondary to an adrenocorticotrophic hormone secreting pituitary adenoma. Primary management is almost always surgical, with limited effective medical interventions available. Adjuvant therapy in the form of radiation is gaining popularity, with the bulk of the literature related to the Gamma Knife. We present the results from our own institution using the linear accelerator (LINAC) since 1990. Thirty-six patients who underwent stereotactic radiosurgery (SRS), one patient who underwent fractionated stereotactic radiotherapy (FSRT) and for the purposes of comparison, 13 patients who had undergone conventional radiotherapy prior to 1990, were included in the analysis. Serum cortisol levels improved in nine of 36 (25%) SRS patients and 24 hour urinary free cortisol levels improved in 13 of 36 patients (36.1%). Tumour volume control was excellent in the SRS group with deterioration in only one patient (3%). The patient who underwent FSRT had a highly aggressive tumour refractory to radiation.